文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

无糖尿病史重症患者胰岛素需求延长对90天死亡率的影响:CONTROLING随机对照试验的事后分析

Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial.
PubMed 文献 · Crit Care · 2022-05-16
一句话结论无糖尿病史ICU患者第5天仅胰岛素需求延长且血糖未达标与90天死亡风险升高相关(IPTWHR=3.34),单纯胰岛素需求延长与死亡无显著关联。

本文为CONTROLING随机对照试验的事后分析,纳入12个法国ICU中个体化血糖控制组、ICU停留≥5天且既往未接受降糖治疗(口服药或胰岛素)的患者476例。根据入院前糖化血红蛋白(HbA1C)估算个体化血糖目标,第5天以胰岛素需求定义胰岛素需求延长(PRI)。全队列90天死亡率为23.1%,PRI组25.3%、非PRI组16.1%(p<0.01)。IPTW分析显示第5天PRI与90天死亡无显著关联(IPTWHR=1.22;95%CI 0.84-1.75;p=0.29),而PRI且血糖未控制与90天死亡风险升高相关(IPTWHR=3.34;95%CI 1.26-8.83;p<0.01)。作者认为需进一步研究确定导致该结果的因素。

要点

  • 无糖尿病史ICU患者第5天PRI发生率72.5%(364/476),全队列90天死亡率23.1%。
  • 第5天PRI且血糖未控制者90天死亡风险升高(IPTWHR=3.34;95%CI 1.26-8.83;p<0.01)。
  • 单纯第5天PRI与90天死亡无显著关联(IPTWHR=1.22;95%CI 0.84-1.75;p=0.29)。
  • PRI组90天死亡率25.3% vs 非PRI组16.1%(p<0.01),但多因素加权后差异未达统计学显著。
  • 血糖控制定义为第5天至少一次血糖值低于血糖目标值。

适用人群与场景

  • CONTROLING试验个体化血糖控制组、ICU停留≥5天、既往从未接受降糖治疗(口服药或胰岛素)的患者。
  • 12个法国ICU的重症患者。

诊断标准与关键阈值

  • 个体化血糖目标根据入院前常用血糖估算,估算依据为糖化血红蛋白(HbA1C)。
  • PRI定义为存在胰岛素需求。
  • 血糖控制定义为第5天至少一次血糖值低于血糖目标值。

研究设计与关键结果

  • 研究类型:CONTROLING随机对照试验的事后分析,涉及12个法国ICU。
  • 样本量:476例,男性62.4%,中位年龄66(54-76)岁,中位SAPS II 50(37.5-64),中位HbA1C 5.7(5.4-6.1)%。
  • 第5天PRI发生率为364/476(72.5%)。
  • 90天死亡率:全队列23.1%,PRI组25.3%,非PRI组16.1%(p<0.01)。
  • 第5天PRI与90天死亡无显著关联:IPTWHR=1.22;95%CI 0.84-1.75;p=0.29。
  • 第5天PRI且血糖未控制与90天死亡风险升高相关:IPTWHR=3.34;95%CI 1.26-8.83;p<0.01。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在无糖尿病史ICU患者中,仅第5天PRI且血糖未控制与死亡风险升高相关,需进一步研究确定导致该结果的因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Stress hyperglycemia can persist during an intensive care unit (ICU) stay and result in prolonged requirement for insulin (PRI). The impact of PRI on ICU patient outcomes is not known. We evaluated the relationship between PRI and Day 90 mortality in ICU patients without previous diabetic treatments.

METHODS: This is a post hoc analysis of the CONTROLING trial, involving 12 French ICUs. Patients in the personalized glucose control arm with an ICU length of stay ≥ 5 days and who had never previously received diabetic treatments (oral drugs or insulin) were included. Personalized blood glucose targets were estimated on their preadmission usual glycemia as estimated by their glycated A1c hemoglobin (HbA1C). PRI was defined by insulin requirement. The relationship between PRI on Day 5 and 90-day mortality was assessed by Cox survival models with inverse probability of treatment weighting (IPTW). Glycemic control was defined as at least one blood glucose value below the blood glucose target value on Day 5.

RESULTS: A total of 476 patients were included, of whom 62.4% were male, with a median age of 66 (54-76) years. Median values for SAPS II and HbA1C were 50 (37.5-64) and 5.7 (5.4-6.1)%, respectively. PRI was observed in 364/476 (72.5%) patients on Day 5. 90-day mortality was 23.1% in the whole cohort, 25.3% in the PRI group and 16.1% in the non-PRI group (p < 0.01). IPTW analysis showed that PRI on Day 5 was not associated with Day 90 mortality (IPTWHR = 1.22; CI 95% 0.84-1.75; p = 0.29), whereas PRI without glycemic control was associated with an increased risk of death at Day 90 (IPTWHR = 3.34; CI 95% 1.26-8.83; p < 0.01).

CONCLUSION: In ICU patients without previous diabetic treatments, only PRI without glycemic control on Day 5 was associated with an increased risk of death. Additional studies are required to determine the factors contributing to these results.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Thouy F, Bohé J, Souweine B, et al. Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial. Crit Care. 2022. PMID: 35578303. doi:10.1186/s13054-022-04004-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。